NCT01865617
- Conditions
- CD19-Positive Neoplastic Cells Present, Chronic Disease, Disease Attributes, +32 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
NCT01865617
NCT01261247
NCT03987542
NCT00416351
NCT04330261
NCT03429387
NCT00061945
NCT00450450
NCT04614935
NCT02670252